Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00914550 · ClinicalTrials.gov registry record

Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia

A clinical trial, sponsored by Winthrop University Hospital.

Completed
Registry status
47
Enrollment target

NCT00914550 is a clinical trial that has completed, run by Winthrop University Hospital. The registered enrollment target is 47 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00914550 has completed, sponsored by Winthrop University Hospital.

COMPLETED
Registry status
47 participants
Enrollment target

Study Summary

The purpose of the study is to learn if a blood test is helpful to the doctors in deciding whether you need antibiotic therapy for possible pneumonia. The blood test is called a Procalcitonin level and sometimes the test reflects infection with certain bacteria (germs). When the doctors learn the results of these blood tests, they may be able to stop some of the antibiotic medications that they may have given to the patients. The study is designed, so that on a randomized basis (50/50 chance) the results from measuring Procalcitonin will be given to the patients' doctor. When the doctor receives these results, he/she may use this information, along with other information, to decide whether to continue antibiotic therapy.

Interventions

  • OTHER Procalcitonin level, caregiver informed

Trial Details

FieldValue
Enrollment Target 47 participants
Start Date 2009-06
Est. Completion 2012-09

Sponsor

Winthrop University Hospital

32 total trials

What the Registry Record Tells You About NCT00914550

The ClinicalTrials.gov registry entry for NCT00914550 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Winthrop University Hospital, which has 32 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Procalcitonin level, caregiver informed is the first listed.

NCT00914550 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00914550 about?

NCT00914550 is a clinical study titled "Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia". The purpose of the study is to learn if a blood test is helpful to the doctors in deciding whether you need antibiotic therapy for possible pneumonia. The blood test is called a Procalcitonin level and sometimes the test reflects infection with certain bacteria (germs). When the doctors learn the re...

What is the current status of trial NCT00914550?

This trial is currently completed. The enrollment target is 47 participants. The study started on 2009-06. Estimated completion is 2012-09.

What interventions are being tested in trial NCT00914550?

The interventions under investigation include: Procalcitonin level, caregiver informed (OTHER).

Who is sponsoring clinical trial NCT00914550?

This trial is sponsored by Winthrop University Hospital, which has 32 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.